Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infectionChen‐Hua Liu, Jia‐Horng Kao, Chih‐Lin Lin et al.|Journal of Hepatology|2024Cited by 33
Dynamic change of metabolic dysfunction-associated steatotic liver disease in patients with hepatitis C virus infection after achieving sustained virologic response with direct-acting antiviralsChen‐Hua Liu, Jia‐Horng Kao, Yu‐Ping Chang et al.|Journal of Gastroenterology|2024Cited by 15
Risk of Incident Type 2 Diabetes and Prediabetes in Patients With Direct Acting Antiviral‐Induced Cure of Hepatitis C Virus InfectionYu‐Ping Chang, Ji‐Yuh Lee, Chi‐Yi Chen et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 12